XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
License revenue $ 7,500,000 $ 54,990
Royalty revenue 206,738
Minimum guaranteed royalties revenue (reversal of variable consideration) (3,121,996) (3,121,996)
Total revenues (3,121,996) 7,706,738 (3,067,006)
Operating expenses:        
Research and development 1,585,233 2,878,798 6,278,881 8,500,319
General and administrative 1,045,240 1,042,572 4,128,371 3,770,281
Total operating expenses 2,630,473 3,921,370 10,407,252 12,270,600
Operating loss (2,630,473) (7,043,366) (2,700,514) (15,337,606)
Other income:        
Interest and investment income 273,574 317,569 913,784 1,067,561
Unrealized gain on warrant liability 138,081 74,827 13,580 200,416
Total other income 411,655 392,396 927,364 1,267,977
Loss before income tax expense (2,218,818) (6,650,970) (1,773,150) (14,069,629)
Income tax expense (681) (200)
Net loss (2,218,818) (6,650,970) (1,773,831) (14,069,829)
Issuance of Series B preferred stock dividend (89)
Net loss attributable to common shareholders $ (2,218,818) $ (6,650,970) $ (1,773,831) $ (14,069,918)
Basic loss per share attributable to common stock $ (0.41) $ (1.26) $ (0.33) $ (2.68)
Weighted average common shares outstanding, basic 5,347,940 5,292,058 5,335,941 5,254,116
Diluted loss per share attributable to common stock $ (0.44) $ (1.27) $ (0.33) $ (2.72)
Weighted average common shares outstanding, diluted 5,347,940 5,292,058 5,335,941 5,254,116
Comprehensive loss:        
Net loss $ (2,218,818) $ (6,650,970) $ (1,773,831) $ (14,069,829)
Net unrealized gain on marketable investment securities 19,661 1,309 2,683 5,818
Comprehensive loss $ (2,199,157) $ (6,649,661) $ (1,771,148) $ (14,064,011)